Results
2661
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
2,661 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
JNJ | US$151.15 | 4.0% | -4.9% | US$362.1b | US$168.45 | PE25.9x | E8.4% | 3.3% | Pharmaceuticals & Biotech | ||
AZN | UK£112.32 | 1.7% | 7.0% | UK£174.2b | UK£138.93 | PE33.3x | E16.9% | 2.0% | Pharmaceuticals & Biotech | ||
HSBA | UK£8.36 | 1.6% | 35.2% | UK£146.9b | UK£8.67 | PB0.9x | E-1.3% | 5.9% | Banks | ||
CBA | AU$160.61 | 1.7% | 40.8% | AU$266.0b | AU$101.65 | PB3.7x | E4.3% | 2.9% | Banks | ||
PFE | US$26.62 | 2.3% | -1.7% | US$151.6b | US$31.13 | PE35.3x | E8.5% | 6.5% | Pharmaceuticals & Biotech | ||
LOW | US$261.73 | 1.4% | 23.0% | US$149.3b | US$282.24 | PE21.6x | E5.9% | 1.8% | Retail | ||
COP | US$101.56 | -1.5% | -9.2% | US$131.1b | US$131.97 | PE13.2x | E1.6% | 3.7% | Energy | ||
BHP | AU$39.48 | 0.9% | -16.2% | AU$198.5b | AU$44.32 | PE15.8x | E6.4% | 5.9% | Materials | ||
TD | CA$82.85 | 1.2% | 1.4% | CA$144.5b | CA$86.47 | PB1.3x | E11.5% | 5.1% | Banks | ||
INVE A | SEK 313.40 | -1.0% | 28.7% | SEK 962.3b | SEK 331.50 | PE8.5x | E-48.3% | 1.7% | Diversified Financials | ||
BP. | UK£4.16 | -2.3% | -10.0% | UK£65.5b | UK£4.80 | PE29.9x | E23.6% | 5.9% | Energy | ||
BREN | Rp9,600.00 | -4.0% | 97.9% | Rp1284.3t | n/a | PE728.5x | n/a | 0.04% | Utilities | ||
ATCO A | SEK 182.05 | -3.6% | 9.0% | SEK 855.6b | SEK 188.52 | PE29.8x | E6.8% | 1.5% | Capital Goods | ||
ITW | US$256.38 | -1.1% | -1.7% | US$76.4b | US$264.31 | PE21.9x | E1.1% | 2.3% | Capital Goods | ||
NAB | AU$39.90 | 1.9% | 25.1% | AU$121.0b | AU$34.11 | PB2x | E2.0% | 4.3% | Banks | ||
1299 | HK$54.25 | -0.8% | -11.0% | HK$580.3b | HK$93.05 | PE15.4x | E13.7% | 3.0% | Insurance | ||
WBC | AU$33.78 | 2.5% | 42.1% | AU$115.0b | AU$28.67 | PB1.6x | E-0.007% | 4.5% | Banks | ||
GSK | UK£14.01 | 3.3% | -10.7% | UK£57.1b | UK£17.94 | PE22.8x | E20.8% | 4.1% | Pharmaceuticals & Biotech | ||
FDX | US$275.06 | 1.7% | 14.0% | US$67.1b | US$323.52 | PE17.1x | E12.9% | 2.0% | Transportation | ||
DGE | UK£24.27 | 1.1% | -15.2% | UK£53.9b | UK£26.42 | PE17.3x | E5.0% | 3.4% | Food, Beverage & Tobacco | ||
CRH | US$99.09 | -1.2% | 38.1% | US$66.7b | US$114.33 | PE19.4x | E9.6% | 1.4% | Materials | ||
CNR | CA$152.23 | 1.4% | -8.7% | CA$95.2b | CA$171.24 | PE17.6x | E4.0% | 2.2% | Transportation | ||
SPG | US$173.63 | 0.4% | 25.3% | US$65.9b | US$186.53 | PB21.2x | E0.4% | 4.8% | Real Estate | ||
KMI | US$27.30 | -11.3% | 61.3% | US$61.0b | US$29.59 | PE23.2x | E9.3% | 4.2% | Energy |